STOCK TITAN

Schedule 13G/A shows 21.07% beneficial stake in NHS

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Neuberger Berman High Yield Strategies Fund Inc. (NHS) received an amended Schedule 13G filing (Amendment No. 9) from First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation disclosing beneficial ownership of 5,463,038 common shares, representing 21.07% of the class, as of 09/30/2025.

The filing lists 0 shares with sole voting power and 0 shares with shared voting power, and 5,463,038 shares with shared dispositive power. The shares are held primarily across unit investment trusts and accounts associated with First Trust; voting for UIT-held shares is conducted by the trustee to mirror unaffiliated holders. The reporting persons state the position is held in the ordinary course of business and not for the purpose of changing or influencing control, and they disclaim beneficial ownership.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



First Trust Portfolios L.P.
Signature:/s/ James M. Dykas
Name/Title:James M. Dykas, Chief Financial Officer
Date:10/22/2025
First Trust Advisors L.P.
Signature:/s/ James M. Dykas
Name/Title:James M. Dykas, Chief Financial Officer
Date:10/22/2025
The Charger Corporation
Signature:/s/ James M. Dykas
Name/Title:James M. Dykas, Chief Financial Officer and Treasurer
Date:10/22/2025
Exhibit Information

Please see Exhibit 99.1 for Joint Filing Agreement

Neuberger Berman High Yield Strategies

NYSE:NHS

NHS Rankings

NHS Latest News

NHS Latest SEC Filings

NHS Stock Data

239.82M
31.08M
Asset Management
Financial Services
Link
United States
New York